Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. intravenous infusion
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Intravenous Infusion Articles & Analysis

13 news found

THY Precision - Plastic Injection Moulding for Medical Devices: A Basic Overview

THY Precision - Plastic Injection Moulding for Medical Devices: A Basic Overview

Our facility includes an ISO Class 8 cleanroom for moulding and an ISO Class 7 cleanroom for assembly, building the sterile and contaminant-free environment for production and packaging.Some medical devices require sterilization services; THY Precision also provides EO (Ethylene Oxide) and Gamma sterilization to help protect millions of patients from the risks of infectious diseases caused by ...

ByHong Yang Precision Industry Co., Ltd.


Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

Forge Biologics Announces Updated Positive Clinical Data in RESKUE, a Novel Phase 1/2 Gene Therapy Trial for Patients with Krabbe Disease

The data from treated subjects demonstrate that intravenous FBX-101 after HSCT infusion has been safe and well tolerated. ...

ByForge Biologics, Inc.


Aikening Launch in Azerbaijan

Aikening Launch in Azerbaijan

Frontier Biotechnologies announced that the Azerbaijan Republic Ministry of Health approved Aikening® (Albuvirtide), the first long-acting intravenous infusion for the treatment of HIV-1 infection in adults. Aikening® is a new fusion inhibitor given once weekly, used in combination dual therapy to treat people living with HIV who have failed initial ...

ByFrontier Biotechnologies Inc.


Rani Therapeutics Unveils High-Capacity RaniPill Device for Oral Delivery of Biologics

Rani Therapeutics Unveils High-Capacity RaniPill Device for Oral Delivery of Biologics

” Today, biologics are predominantly delivered via injection or intravenous infusion, which limits long-term treatment adherence, often leading to suboptimal patient outcomes. ...

ByRani Therapeutics


Affimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)

Affimed Highlights Trial Designs of Three AFM24 Ongoing Clinical Studies at the Annual Meeting of the American Society of Clinical Oncology (ASCO)

Escalating doses of AFM24 will be given to each cohort as weekly intravenous (IV) infusions. The starting dose and at least two planned dose escalations are based on results from the ongoing AFM24 monotherapy trial. Atezolizumab is given at a fixed dose of 840 mg biweekly IV infusion. Patients will receive AFM24 and atezolizumab treatment until ...

ByAffimed GmbH


Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association

Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association

Each patient received a single intravenous infusion of low- or high-dose Lomecel-B, or a placebo. The findings from this study are being tested in a new larger Phase 2 study, which commenced in December 2021, and has already treated the first patient and continues to enroll others. ...

ByLongeveron, Inc.


Capricor Therapeutics Reports Topline Results from Phase 2 Exploratory INSPIRE Trial in Severe Hospitalized COVID-19 Patients

Capricor Therapeutics Reports Topline Results from Phase 2 Exploratory INSPIRE Trial in Severe Hospitalized COVID-19 Patients

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics, announced today that its Phase 2, INSPIRE study evaluating a single-dose intravenous infusion of CAP-1002 as a potential treatment option for hospitalized patients with advanced symptoms of COVID-19 met its primary ...

ByCapricor Therapeutics, Inc.


Ascelia Pharma presents clinical development plan for Oncoral as a novel chemotherapy

Ascelia Pharma presents clinical development plan for Oncoral as a novel chemotherapy

Today, the administration of irinotecan is intravenous (IV) bolus infusions, typically as a high dose every third week. ...

ByAscelia Pharma AB


Dexamethasone reportedly part of President Trump’s Treatment

Dexamethasone reportedly part of President Trump’s Treatment

AVM0703 is a high-concentration and high-volume formulation of dexamethasone sodium phosphate (DSP) for intravenous (IV) infusion. This proprietary formulation does not contain dose-limiting excipients such as benzyl alcohol and parabens found in generic formulations and could possibly be used at up to 21 mg/kg per dose. AVM0703 is administered as a single IV ...

ByAVM Biotechnology


Thermo Fisher Scientific and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer

Thermo Fisher Scientific and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer

Adverse Reactions The safety of ENHERTU was evaluated in a pooled analysis of 234 patients with unresectable or metastatic HER2-positive breast cancer who received at least one dose of ENHERTU 5.4 mg/kg in DESTINY-Breast01 and Study DS8201-A-J101. ENHERTU was administered by intravenous infusion once every three weeks. The median duration of treatment was 7 ...

ByThermo Fisher Scientific, LIMS & Laboratory Software


Tissue Genesis` Icellator X Delivers Results in First Clinical Application

Tissue Genesis` Icellator X Delivers Results in First Clinical Application

Manufactured under cGMP to the highest ISO 13485 and FDA standards, the Icellator® product line requires no human intervention after initial setup and within approximately one hour, provides yields of stromal vascular fraction that is sufficiently pure to allow for intravenous infusion. Founded in 2001, Tissue Genesis is dedicated to accelerating life ...

ByTissue Genesis


Tissue Genesis, LLC Provides Cell Isolation Processing for Patients with Critical Limb Ischemia (CLI) in Ukrainian Clinical Study

Tissue Genesis, LLC Provides Cell Isolation Processing for Patients with Critical Limb Ischemia (CLI) in Ukrainian Clinical Study

Manufactured under cGMP to the highest ISO 13485 and FDA standards, the Icellator® provides yields of stromal vascular fraction that is sufficiently pure to allow for intravenous infusion in an hour or less. Tissue Genesis’ Icellator® is approved for use by medical regulatory authorities in South Korea, Ukraine and the Bahamas, and is working to ...

ByTissue Genesis


Tissue Genesis Introduces State-of-the-Art Icellator X

Tissue Genesis Introduces State-of-the-Art Icellator X

Manufactured under cGMP to the highest ISO 13485 and FDA standards, the Icellator® requires no human intervention and provides yields of stromal vascular fraction that is sufficiently pure to allow for intravenous infusion in an hour or less. Founded in 2001, TG is part of the Okyanos Global Health, Inc. portfolio of companies dedicated to accelerating life ...

ByTissue Genesis

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT